Last deal
Amount
Stage
Date
all rounds
Total amount
date founded
Financing round
General
About Company
Industry
Sector :
Subsector :
founded date
founders
Number of employees
Company Type
Last funding type
IPO status
Contacts
Contact Email
Phone number
Website URL
Similar Companies1000
Andes Biotechnologies
Andes Biotechnologies is developing drugs for cancer treatment based on oligonucleotide drugs.
Sector
Subsector
Location
total rounds
Minerva Biotechnologies
Minerva Biotechnologies develops cancer immunotherapies and stem cell technologies for regenerative medicine.
Sector
Subsector
Location
total rounds
total raised
Patrys
Patrys develops natural human antibody-based therapeutic products for the treatment of cancer and infectious diseases.
Sector
Subsector
Keywords
Location
Advanced Proteome Therapeutics
Advanced Proteome Therapeutics is a biotech company that develops novel therapeutics for cancer treatment.
Sector
Subsector
Keywords
Location
total rounds
total raised
Financials
Funding Rounds3
Number of Funding Rounds
Money Raised
Their latest funding was raised on 26.07.2023. Their latest investor MassChallenge. Their latest round Non-equity Assistance
MassChallenge
MassChallenge is a global accelerator that supports startups without taking equity.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Carao Ventures
Carao Ventures is a venture capital firm that invests in early-stage startups led by founders from Latin America's small and medium markets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Carao Ventures
Carao Ventures is a venture capital firm that invests in early-stage startups led by founders from Latin America's small and medium markets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Co-Investors
Investors2
Number of lead investors
Number of investors
MassChallenge
MassChallenge is a global accelerator that supports startups without taking equity.
Sector
Subsector
Keywords
Location
total rounds
total raised
count Of Investments
count Of Exists
Chaya Pomeranz-Sherman
Chaya Pomeranz-Sherman is a manager at MassChallenge.
Carao Ventures
Carao Ventures is a venture capital firm that invests in early-stage startups led by founders from Latin America's small and medium markets.
Sector
Subsector
Keywords
Location
count Of Investments
count Of Exists
Allan Boruchowicz
Allan is Founder and Managing Director at Carao Ventures. He has more than 10 years experience managing private equity investments and has worked and invested in startups in different stages for the last 6 years in Latin America and the US. He founded Carao Ventures in 2012 aiming to offer entrepreneurs in Latin America the same resources and opportunities that entrepreneurs in more developed markets have available to create and advance their startups. At Carao Ventures, Allan leads the investments in Slidebean, BildTEK, Speratum, and Singularities in which he is mentor and Board Member of the companies. Also, he leads the acceleration program for GoPass, Huli, Aerial Robotixs, and Quenti on behalf of the firm. Before founding Carao Ventures, Allan worked for more than 5 years at Mesoamerica Investments, a consulting and private equity management firm in Latin America, at first from the Costa Rican office and afterwards establishing operations of the firm in South America, with office overseeing the region based in Bogotá, Colombia. Prior to working in Mesoamerica, Allan worked for a year managing investments at UBS Wealth Management US. Currently, Allan serves on the Board of Directors of Banco BCT, BCT Puesto de Bolsa, and BCT SAFI; and is Member of the Investment Committee of CRUSA Foundation. Allan has a B.Sc. degree in Business Management with concentration in Finance and Entrepreneurship from Babson College.
current job
organization founded
People
Founders1
Christian Marin-Muller
(PhD, Molecular Virology and Microbiology, Baylor College of Medicine; MS, Entrepreneurial Biotechnology, Case Western Reserve University/Weatherhead School of Management; BS, Molecular Biology, Florida Tech) Dr. Marin-Müller has worked in the field of cancer therapeutics for almost a decade, with a specific focus on the use of RNA interference technology and development of nanotechnology-based delivery of therapeutics against solid tumors. He is co-inventor of a therapeutic miRNA treatment that can control a network of biomarkers responsible for aggressive growth and metastasis in pancreatic cancer, and has the potential to completely eliminate tumors both alone and in combination with existing modalities. In addition to his focus on research, Dr. Marin-Müller has also been heavily involved in the biotech industry ecosystem. He has co-founded several biotechnology and service companies, and has worked as a consultant to multiple start-up and governmental organizations, contributing to the development of projects ranging from medical devices to HIV vaccine investigation.
current job
organization founded
Christian Marin-Muller